Key Points Three nuclear energy companies occupy the top spots with returns ranging from 556.9% to 712.29%. Data center power ...

LB Pharma needed $350 million to advance a promising schizophrenia candidate at a time when the biotech markets were locked up tight. Fortunately, it wasn’t CEO Heather Turner’s first rodeo.

Choosing between a SPAC and an IPO is about cost of capital, certainty of outcome, timing and the investor base you want to ...

Fact checked by Suzanne Kvilhaug Reviewed by Marguerita Cheng Key Takeaways Researching a company's IPO is crucial for understanding long-term prospects.A strong underwriter often signals a ...

Prediction markets like Kalshi have attracted significant interest, especially in recent years.

Leaders recommend preparing for an IPO well in advance and tailoring the process to a company's needs. The discussion was part of BI's event "The Road to IPO," in collaboration with Fidelity and held ...

The biotech IPO market this year has made one thing obviously clear. It’s a wasteland when it comes to the same for medical devices. “In contrast to biotech, the medtech IPO market has been notably ...

This transcript was prepared by a transcription service. This version may not be in its final form and may be updated. Raakhee Mirchandani: The content in this podcast was relevant when published on ...

As the old saying goes, "Sometimes, it's better to be lucky than to be good." It was at this propitious moment in time that Voyager Technologies decided it, too, would go public. Wooing investors with ...

Discover how IPO pricing works, from market demand and industry comparables to projected growth, and learn how to assess if a stock is priced appropriately.

The IPO market began to show signs of life last year, and that momentum is expected to carry over into 2025. According to Renaissance Capital, IPO proceeds surged over 50% last year, powered by ...